This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pulmonary Diseases  • Pulmonary Diseases, Other  • Endocrine Diseases  • Diabetes Mellitus  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Christopher J. Magryta, MD; Randolph Hennigar, MD; Mark Weatherly, MD
From the Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga. Dr Magryta is now with the Salisbury Children's Clinic, Salisbury, NC, and Dr Weatherly is now with the Nemours Children's Foundation, Orlando, Fla.

Arch Pediatr Adolesc Med. 1999;153:1307-1308.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A 15-YEAR-OLD WHITE BOY was diagnosed as having cystic fibrosis (CF) at age 4 years after symptoms of projectile vomiting, bulky stools, and anemia. Of 32 alleles tested, his genotype is N1303K/unidentified allele. He had multiple hospital admissions through age 2 years and only 4 until 1991, age 7 years. In 1994, he had a biliary tract obstruction requiring endoscopic intervention. In February 1991, he was diagnosed as having diabetes mellitus (DM) glucose intolerance. Subsequently, a therapeutic regimen of glipizide and a diet with no concentrated sweets was begun. Later that year, during a hospitalization, he had sustained elevated serum glucose levels while receiving prednisone. His hemoglobin A_1c level was 6.1 mg/dL. Urine protein was monitored regularly from 1991 through 1994, and traces began to appear in June 1992 but did not reach high levels until 1994. At hospital admission, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?